Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anders Perner1,2, Maj-Brit N Kjær1, Hans-Christian Thorsen-Meyer1

  • 1Afdeling for Intensiv Behandling, Center for Kræft og Organsygdomme, Københavns Universitetshospital - Rigshospitalet.

Ugeskrift for Laeger
|October 24, 2023
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of Prokinetic Agents in Adult ICU Patients: An International Inception Cohort Study (PATIENCE).

Acta anaesthesiologica Scandinavica·2026
Same author

Developing a Core Outcome Measurement Set for Adult ICU Patients, the CoreMS-ICU-A Protocol.

Acta anaesthesiologica Scandinavica·2026
Same author

Preferences for Blood Glucose Management in Adult Intensive Care Unit Patients-An International Survey.

Acta anaesthesiologica Scandinavica·2026
Same author

ICU Clinicians' View on Platelet Transfusion Thresholds for a Future Trial-Protocol for an International Survey.

Acta anaesthesiologica Scandinavica·2026
Same author

Key Features of Contemporary Pilot and Feasibility Trials: Protocol for a Methodological Study.

Acta anaesthesiologica Scandinavica·2026
Same author

Key considerations for planning adaptive platform trials: part 1.

Journal of clinical epidemiology·2026
Same journal

[Mosaicism as a cause of Cowden syndrome].

Ugeskrift for laeger·2026
Same journal

[Thyrotoxic crisis with cardiogenic shock].

Ugeskrift for laeger·2026
Same journal

[Mindfulness-based cognitive therapy in the treatment of depression].

Ugeskrift for laeger·2026
Same journal

[Fitness].

Ugeskrift for laeger·2026
Same journal

[Risk of developing cataract related to fluoroscopy].

Ugeskrift for laeger·2026
Same journal

[Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

Ugeskrift for laeger·2026
See all related articles
This summary is machine-generated.

Platform trials efficiently test multiple interventions using adaptive designs. The Intensive Care Platform Trial (INCEPT) exemplifies their speed and validity in improving treatments, as highlighted by the COVID-19 pandemic.

Area of Science:

  • Clinical trial methodology
  • Adaptive trial designs
  • Public health research

Background:

  • Platform trials enable continuous evaluation of numerous interventions within a specific disease or setting.
  • These trials establish robust, long-term frameworks for organization, administration, data management, analysis, and operations, enhancing efficiency.
  • Adaptive strategies within platform trials improve participant allocation to superior interventions and increase the likelihood of definitive outcomes.

Approach:

  • This review provides a comprehensive overview of platform trial concepts and essential components.
  • The Intensive Care Platform Trial (INCEPT) is utilized as a case study to illustrate these principles.
  • The discussion highlights the efficiency and adaptability inherent in platform trial structures.

Key Points:

Related Experiment Videos

  • Platform trials offer a highly efficient model for sustained intervention testing.
  • Adaptive elements enhance the probability of identifying effective treatments and achieving conclusive results.
  • The COVID-19 pandemic underscored the value of platform trials for rapid therapeutic advancement.

Conclusions:

  • Platform trials represent an efficient and adaptable approach to medical research.
  • The INCEPT trial serves as a practical example of implementing platform trial methodologies.
  • These trial designs are crucial for accelerating the development of improved treatments, particularly in critical care settings.